Croma-Pharma, an Austria-based company, has announced the expansion of its product portfolio in Canada with the launch of two new offerings: saypha® lips Lidocaine and Exprecell™. The saypha® lips Lidocaine is a hyaluronic acid filler designed specifically for lip augmentation, enhancing the aesthetic appeal of the lips. The Exprecell™ device is utilized for preparing autologous Platelet-Rich Plasma (PRP) and Fluid-PRF, which are often used in various cosmetic and medical applications, including skin rejuvenation and healing treatments.
These products are set to be distributed by Renellence, a Canadian partner of Croma since 2025. Croma's decision to expand its offerings in Canada is part of a larger strategy to integrate established hyaluronic acid technologies with newer regenerative practices. This move is aimed at leveraging the growing demand for aesthetic treatments in the Canadian market and underscores Croma’s commitment to providing innovative solutions in aesthetic medicine. The introduction of these products may enhance the options available to practitioners and patients in Canada seeking advanced aesthetic treatments.
Analyzed Canadian Outlets (1)
1 headline